{
  "doc_id": "1_interrelationsbetweendiseaseandnutrition__bf911d",
  "original_filename": "1_InterrelationsBetweenDiseaseandNutrition.pdf",
  "md_path": "data/parsed/1_InterrelationsBetweenDiseaseandNutrition/1_InterrelationsBetweenDiseaseandNutrition.md",
  "rmd_path": "data/parsed/1_InterrelationsBetweenDiseaseandNutrition/1_InterrelationsBetweenDiseaseandNutrition.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT CERTIFICATE",
      "line": 0
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Interrelations Between Disease and Nutrition",
      "line": 2
    },
    {
      "type": "image",
      "section": "Interrelations Between Disease and Nutrition",
      "line": 4,
      "content": "![img-0.jpeg](images/545f9225f87911e2.png)"
    },
    {
      "type": "text",
      "section": "Interrelations Between Disease and Nutrition",
      "line": 6,
      "preview": "LEADING THE SCIENCE AND PRACTICE OF CLINICAL NUTRITION"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).",
      "line": 8
    },
    {
      "type": "text",
      "section": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).",
      "line": 10,
      "preview": "\u00a92022 American Society of Health-System Pharmacists, Inc. All rights reserved."
    },
    {
      "type": "text",
      "section": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).",
      "line": 11,
      "preview": "No part of this publication may be reproduced or transmitted in any form or by any means, electronic"
    },
    {
      "type": "text",
      "section": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).",
      "line": 13,
      "preview": "--- page 1 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "INTERRELATIONS BETWEEN DISEASE AND NUTRITION",
      "line": 15
    },
    {
      "type": "text",
      "section": "INTERRELATIONS BETWEEN DISEASE AND NUTRITION",
      "line": 17,
      "preview": "Jay M Mirtallo, M.S., R.Ph., BCNSP, FASHP, FASPEN"
    },
    {
      "type": "text",
      "section": "INTERRELATIONS BETWEEN DISEASE AND NUTRITION",
      "line": 18,
      "preview": "The Ohio State University College of Pharmacy ASPEN"
    },
    {
      "type": "text",
      "section": "INTERRELATIONS BETWEEN DISEASE AND NUTRITION",
      "line": 20,
      "preview": "NUTRITION SUPPORT CERTIFICATE"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 22
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 24,
      "preview": "The following persons in control of this activity's content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 26,
      "preview": "- Jay M. Mirtallo: Fresenius Kabi, consultant"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 28,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 30,
      "preview": "As defined by the Standards of Integrity and Independence definition of ineligible company. All rele"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 32,
      "preview": "--- page 2 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "LEARNING OBJECTIVES",
      "line": 34
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 36,
      "preview": "- Differentiate between disease and nutritional issues in specific disease states."
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 37,
      "preview": "- Select appropriate nutrition interventions to mitigate disease specific consequences on clinical o"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "KEY ABBREVIATIONS",
      "line": 40
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 42,
      "preview": "- Ca:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 43,
      "preview": "- EN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 44,
      "preview": "- GUT or GI:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 45,
      "preview": "- LBM:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 46,
      "preview": "- Mg :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 47,
      "preview": "- NPO:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 48,
      "preview": "- PN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 49,
      "preview": "- SBS:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 50,
      "preview": "- SAP:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 51,
      "preview": "- SIRS:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 52,
      "preview": "- Zn : calcium"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 53,
      "preview": "enteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 54,
      "preview": "gastrointestinal tract"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 55,
      "preview": "lean body mass"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 56,
      "preview": "magnesium"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 57,
      "preview": "nil per os, nothing by mouth"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 58,
      "preview": "parenteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 59,
      "preview": "short bowel syndrome"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 60,
      "preview": "severe acute pancreatitis"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 61,
      "preview": "systemic inflammatory response syndrome"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 62,
      "preview": "zinc"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 64,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "DEFINITIONS",
      "line": 66
    },
    {
      "type": "text",
      "section": "DEFINITIONS",
      "line": 68,
      "preview": "- Short Bowel Syndrome: Inadequate absorptive capacity for sustenance with normal diet"
    },
    {
      "type": "text",
      "section": "DEFINITIONS",
      "line": 69,
      "preview": "- Intestinal Failure: Inadequate absorptive capacity for sustenance"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 72
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 74,
      "preview": "SG is admitted to the intensive care unit with a severe intra-abdominal infection following an intes"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 75,
      "preview": "A. Initiate enteral feeding as soon as possible"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 76,
      "preview": "B. Initiate parenteral nutrition until enteral feeding access can be obtained"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 77,
      "preview": "C. Nutrition is not an issue in this patient"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 78,
      "preview": "D. Withhold nutrition support until the patient stabilizes (within 24-48 hours)"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 80,
      "preview": "--- page 4 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 82
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 84,
      "preview": "SM is admitted to the intensive care unit with severe acute pancreatitis. What nutrition approach co"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 85,
      "preview": "A. Initiate enteral feeding as soon as possible"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 86,
      "preview": "B. Initiate parenteral nutrition until enteral feeding access can be obtained"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 87,
      "preview": "C. Nutrition is not an issue in this patient"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 88,
      "preview": "D. Withhold nutrition support until the patient stabilizes (within 24-48 hours)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "INFLAMMATION",
      "line": 90
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 92,
      "preview": "- Inflammation is common to diseases requiring nutrition support and predispose to malnutrition via:"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 93,
      "preview": "- Anorexia, altered intake"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 94,
      "preview": "- Increased nutrient losses - gastrointestinal disorders"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 95,
      "preview": "- Nausea, vomiting"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 96,
      "preview": "- Fistulas - abnormal communication with two or more organs"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 97,
      "preview": "- Gastroduodenal - stomach to duodenum"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 98,
      "preview": "- Nutrient intake may be adequate but poor utilization due to:"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 99,
      "preview": "- Hyper- or altered metabolism"
    },
    {
      "type": "text",
      "section": "INFLAMMATION",
      "line": 101,
      "preview": "--- page 5 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 103
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 105,
      "preview": "| Physiologic Function | Response | Nutritional consequence |"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 106,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 107,
      "preview": "| Energy expenditure | $\\uparrow \\uparrow \\uparrow$ | Expenditure in excess of energy intake creatin"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 108,
      "preview": "| Catabolism - protein breakdown | $\\uparrow \\uparrow \\uparrow$ | Breakdown in excess of intake or s"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 109,
      "preview": "| Protein synthesis | No Change or $\\uparrow$ | Change out of proportion with catabolism |"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 111
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 113,
      "preview": "| Physiologic Function | Response | Nutritional consequence |"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 114,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 115,
      "preview": "| Ureagenesis (protein waste) | $\\uparrow \\uparrow$ | Limited tolerance to protein doses required to"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 116,
      "preview": "| Gluconeogenesis | $\\uparrow \\uparrow \\uparrow$ | Glucose difficult to control, creates worse outco"
    },
    {
      "type": "table",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 117,
      "preview": "| Response to feeding | $\\downarrow \\downarrow$ | Nutritional response dictated by injury response -"
    },
    {
      "type": "text",
      "section": "METABOLIC RESPONSE TO INJURY",
      "line": 119,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RELATIONSHIP OF INFLAMMATORY RESPONSE AND NUTRITION",
      "line": 121
    },
    {
      "type": "image",
      "section": "RELATIONSHIP OF INFLAMMATORY RESPONSE AND NUTRITION",
      "line": 123,
      "content": "![img-1.jpeg](images/fdca67f5a6069e0e.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "CRITICAL CARE AND SURGERY",
      "line": 125
    },
    {
      "type": "text",
      "section": "CRITICAL CARE AND SURGERY",
      "line": 127,
      "preview": "- Marked elevation of energy expenditure, protein catabolism and mobilization of fat for use as an e"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE AND SURGERY",
      "line": 128,
      "preview": "- Predisposition to hyperglycemia, hypertriglyceridemia and azotemia"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE AND SURGERY",
      "line": 129,
      "preview": "- Poor tolerance to nutrition support"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE AND SURGERY",
      "line": 130,
      "preview": "- Metabolic support - provide enough substrate to prevent nutrient deficiency or protein/calorie mal"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE AND SURGERY",
      "line": 131,
      "preview": "- Accentuated loss of LBM and shortened time to develop malnutrition"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE AND SURGERY",
      "line": 133,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CRITICAL CARE",
      "line": 135
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 137,
      "preview": "- Severe sepsis - shock"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 138,
      "preview": "- Dysautoregulation or aberrant metabolism where infusion of nutrients may be harmful"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 139,
      "preview": "- Clinical application: withhold or withdraw nutrition support"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 140,
      "preview": "- Unstable ICU patient unable to maintain blood pressure or tissue oxygenation"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 141,
      "preview": "- Hold nutrition support (EN, PN) during major operative procedures"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 142,
      "preview": "- Acute emergency requiring resuscitation (code)"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 143,
      "preview": "- Discontinue EN/PN until condition stabilizes"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 145,
      "preview": "Martindale RG et al. The ASPEN adult nutrition support core"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 146,
      "preview": "NUTRITION SUPPORT"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 147,
      "preview": "curriculum. 3rd ed. 2017:458-59."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "CRITICAL CARE",
      "line": 149
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 151,
      "preview": "- Important to recognize transition of care responsibilities when patient moves to or from critical "
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 152,
      "preview": "- Assume there is a change in the requirement for calories and protein as well as the proportion of "
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 153,
      "preview": "- Likely increased when transfer to and decreased when discharged from critical care"
    },
    {
      "type": "text",
      "section": "CRITICAL CARE",
      "line": 155,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 157
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 159,
      "preview": "- Metabolic abnormalities"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 160,
      "preview": "- Carbohydrate"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 161,
      "preview": "- Protein"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 162,
      "preview": "- Fat"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 163,
      "preview": "- Clinical Features"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 164,
      "preview": "- Tissue wasting"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 165,
      "preview": "- Anorexia"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 166,
      "preview": "- Skeletal muscle atrophy"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 167,
      "preview": "- Anergy"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 168,
      "preview": "- Fatigue"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 169,
      "preview": "- Anemia"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA (PROGRESSIVE INVOLUNTARY WEIGHT LOSS)",
      "line": 170,
      "preview": "- Hypoalbuminemia"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "CANCER CACHEXIA, CONT.",
      "line": 173
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 175,
      "preview": "- Causes"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 176,
      "preview": "- Anorexia"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 177,
      "preview": "- Mechanical factors affecting the GI tract from tumors"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 178,
      "preview": "- Side effects of surgery, chemotherapy, radiation therapy"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 179,
      "preview": "- Alterations in intermediary and energy metabolism"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 180,
      "preview": "- Changes in host cytokine and hormonal milieu"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 181,
      "preview": "- Lean Body Mass = Survival"
    },
    {
      "type": "text",
      "section": "CANCER CACHEXIA, CONT.",
      "line": 183,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 185
    },
    {
      "type": "text",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 187,
      "preview": "- $50 \\%$ of patients with cancer present with weight loss at diagnosis"
    },
    {
      "type": "text",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 188,
      "preview": "- Unintentional weight loss depletes the LBM"
    },
    {
      "type": "text",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 189,
      "preview": "- Weight loss correlates with decreased performance status and survival following chemotherapy"
    },
    {
      "type": "table",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 191,
      "preview": "| Characteristic | \\% Wt Loss | Type of Cancer |"
    },
    {
      "type": "table",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 192,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 193,
      "preview": "| Lowest | $31-40$ | Sarcoma, breast, hematologic |"
    },
    {
      "type": "table",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 194,
      "preview": "| Intermediate | $54-64$ | Colon, prostate, lung |"
    },
    {
      "type": "table",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 195,
      "preview": "| Highest | $>80$ | Pancreas, gastric |"
    },
    {
      "type": "text",
      "section": "CANCER: PREVALENCE OF MALNUTRITION",
      "line": 197,
      "preview": "Dewys WD et al. Am J Med. 1980; 69(9):491-97."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "MALNUTRITION IN CANCER",
      "line": 199
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 201,
      "preview": "- Affected by:"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 202,
      "preview": "- Tumor type, location, grade and stage"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 203,
      "preview": "- Anticancer treatment"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 204,
      "preview": "- Patient characteristics"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 205,
      "preview": "- Age, gender"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 206,
      "preview": "- Comorbidities: diabetes, intestinal disorders"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 207,
      "preview": "- Associated with longer hospital stay, $\\uparrow$ cost and $\\uparrow$ morbidity/mortality"
    },
    {
      "type": "text",
      "section": "MALNUTRITION IN CANCER",
      "line": 209,
      "preview": "--- page 10 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 211
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 213,
      "preview": "- Due to metabolic abnormalities present in cancer patients, the use of nutrition support in those w"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 214,
      "preview": "- Benefits versus Risk"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 215,
      "preview": "- Patient - family considerations"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 216,
      "preview": "- Social situation versus medical benefit"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 217,
      "preview": "- Informed consent"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN CANCER: ETHICAL CONSIDERATIONS",
      "line": 219,
      "preview": "Schwartz DB et al. The ASPEN adult nutrition support core curriculum. 3rd ed. 2017:785-804."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ACUTE PANCREATITIS",
      "line": 221
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 223,
      "preview": "- Disease progression and phases"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 224,
      "preview": "- Inflammatory process initiated by intra-acinar activation of proteolytic enzymes causing auto dige"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 225,
      "preview": "- Local or systemic presence of disease relevant to prognosis"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 226,
      "preview": "- An acute inflammatory reaction involving cytokines"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 227,
      "preview": "- Initial phase is local and presents as abdominal pain"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 228,
      "preview": "- Systemic phase induced by the inflammatory response develops over 13 days"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 229,
      "preview": "- Severity of this phase (SIRS) influences the outcome of acute pancreatitis"
    },
    {
      "type": "text",
      "section": "ACUTE PANCREATITIS",
      "line": 231,
      "preview": "--- page 11 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 233
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 235,
      "preview": "- Severe Acute Pancreatitis usually requires nutrition support"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 236,
      "preview": "- Disease manifestations complicate the delivery, utilization and beneficial effects of nutrients"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 237,
      "preview": "- Barriers to implementing best practices for nutrition in pancreatitis"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 238,
      "preview": "- 'GUT' rest"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 239,
      "preview": "- Recommendations for specific enteral tube placement"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 240,
      "preview": "- Metabolic complications of nutrition therapy"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 241,
      "preview": "- Therapeutic Objectives"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 242,
      "preview": "- Attenuate Inflammatory response"
    },
    {
      "type": "text",
      "section": "OVERVIEW OF NUTRITION IN PANCREATITIS",
      "line": 243,
      "preview": "- Prevent or treat malnutrition"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "NUTRITION MANAGEMENT IN SAP",
      "line": 246
    },
    {
      "type": "text",
      "section": "NUTRITION MANAGEMENT IN SAP",
      "line": 248,
      "preview": "- Metabolic disturbances are common in pancreatitis"
    },
    {
      "type": "text",
      "section": "NUTRITION MANAGEMENT IN SAP",
      "line": 249,
      "preview": "- Hyperglycemia - 40-90\\%"
    },
    {
      "type": "text",
      "section": "NUTRITION MANAGEMENT IN SAP",
      "line": 250,
      "preview": "- Hypertriglyceridemia - 12-15\\%"
    },
    {
      "type": "text",
      "section": "NUTRITION MANAGEMENT IN SAP",
      "line": 251,
      "preview": "- Hypocalcemia - present due to reduced parathyroid function, increased calcitonin levels, reduced m"
    },
    {
      "type": "text",
      "section": "NUTRITION MANAGEMENT IN SAP",
      "line": 253,
      "preview": "--- page 12 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT IN SEVERE ACUTE PANCREATITIS",
      "line": 255
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN SEVERE ACUTE PANCREATITIS",
      "line": 257,
      "preview": "- 'GUT' rest and NPO is no longer considered the primary treatment."
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN SEVERE ACUTE PANCREATITIS",
      "line": 258,
      "preview": "- PN should be avoided and only used if EN is not feasible"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN SEVERE ACUTE PANCREATITIS",
      "line": 259,
      "preview": "- Persistent gastric ileus or small bowel obstruction and enteral access not possible"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN SEVERE ACUTE PANCREATITIS",
      "line": 260,
      "preview": "- Exacerbation of pancreatic symptoms despite nasojejunal delivery and use of elemental formula"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT IN SEVERE ACUTE PANCREATITIS",
      "line": 261,
      "preview": "- Gastrointestinal intolerance - abdominal pain, ascites, elevated pancreatic fistula output"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SHORT BOWEL SYNDROME",
      "line": 264
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 266,
      "preview": "Surgical Resection"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 268,
      "preview": "- SB length"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 269,
      "preview": "- 100-120 cm without a colon"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 270,
      "preview": "- 50 cm with colon"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 271,
      "preview": "- Etiology"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 272,
      "preview": "- Crohn's"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 273,
      "preview": "- Volvulus"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 274,
      "preview": "- Trauma"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 275,
      "preview": "- Malignancy"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 276,
      "preview": "- Radiation enteritis"
    },
    {
      "type": "text",
      "section": "SHORT BOWEL SYNDROME",
      "line": 278,
      "preview": "--- page 13 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 280
    },
    {
      "type": "text",
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 282,
      "preview": "- Jejunal resection of 50-60\\% well tolerated"
    },
    {
      "type": "text",
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 283,
      "preview": "- $>30 \\%$ ileal resection poorly tolerated"
    },
    {
      "type": "text",
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 284,
      "preview": "- Severe malabsorption with residual bowel $<60 \\mathrm{~cm}$"
    },
    {
      "type": "text",
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 285,
      "preview": "- Deficiencies fluid and electrolytes"
    },
    {
      "type": "text",
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 286,
      "preview": "- Severe fluid and electrolyte loss with end jejunostomy"
    },
    {
      "type": "text",
      "section": "CLINICAL CONSEQUENCES OF SBS",
      "line": 287,
      "preview": "- $\\mathrm{Mg}, \\mathrm{Ca}, \\mathrm{Zn}$ deficiencies are common"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "NUTRITIONAL ISSUES",
      "line": 290
    },
    {
      "type": "text",
      "section": "NUTRITIONAL ISSUES",
      "line": 292,
      "preview": "- Need for long-term and often life-time nutrition support with parenteral nutrition or combined ora"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL ISSUES",
      "line": 293,
      "preview": "- Nutrition assessment must be comprehensive with an awareness of increased probability of nutrition"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL ISSUES",
      "line": 294,
      "preview": "- Transitions of care are important when patient moves between healthcare settings (hospital - home,"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL ISSUES",
      "line": 295,
      "preview": "- For home parenteral nutrition patients with central venous catheter infections and prolonged perio"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL ISSUES",
      "line": 297,
      "preview": "--- page 14 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 299
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 301,
      "preview": "SG is admitted to the intensive care unit with a severe intra-abdominal infection following an intes"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 302,
      "preview": "A. Initiate enteral feeding as soon as possible"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 303,
      "preview": "B. Initiate parenteral nutrition until enteral feeding access can be obtained"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 304,
      "preview": "C. Nutrition is not an issue in this patient"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 305,
      "preview": "D. Withhold nutrition support until the patient stabilizes (within 24-48 hours)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 307
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 309,
      "preview": "SG is admitted to the intensive care unit with a severe intra-abdominal infection following an intes"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 310,
      "preview": "A. Initiate enteral feeding as soon as possible"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 311,
      "preview": "B. Initiate parenteral nutrition until enteral feeding access can be obtained"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 312,
      "preview": "C. Nutrition is not an issue in this patient"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 313,
      "preview": "D. Withhold nutrition support until the patient stabilizes (within 24-48 hours)"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 315,
      "preview": "--- page 15 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 317
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 319,
      "preview": "SM is admitted to the intensive care unit with severe acute pancreatitis. What nutrition approach co"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 320,
      "preview": "A. Initiate enteral feeding as soon as possible"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 321,
      "preview": "B. Initiate parenteral nutrition until enteral feeding access can be obtained"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 322,
      "preview": "C. Nutrition is not an issue in this patient"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 323,
      "preview": "D. Withhold nutrition support until the patient stabilizes (within 24-48 hours)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 325
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 327,
      "preview": "SM is admitted to the intensive care unit with severe acute pancreatitis. What nutrition approach co"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 328,
      "preview": "A. Initiate enteral feeding as soon as possible"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 329,
      "preview": "B. Initiate parenteral nutrition until enteral feeding access can be obtained"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 330,
      "preview": "C. Nutrition is not an issue in this patient"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 331,
      "preview": "D. Withhold nutrition support until the patient stabilizes (within 24-48 hours)"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 333,
      "preview": "--- page 16 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CONCLUSIONS",
      "line": 335
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 337,
      "preview": "- Inflammation is common to all disease states which predisposes to malnutrition and impedes the res"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 338,
      "preview": "- Individual diseases may elicit unique contributions to the development of malnutrition that requir"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 339,
      "preview": "- Certain conditions where nutrition may not be as beneficial and risk is high may warrant either wi"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "REFERENCES",
      "line": 342
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 344,
      "preview": "- Dewys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 345,
      "preview": "- Evans DC, Collier BR. Trauma, surgery and burns. In: Mueller C, ed. The ASPEN adult nutrition supp"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 346,
      "preview": "- Martindale RG, Patel JJ, Herron TJ, Codner PA. Sepsis and critical illness. In: Mueller C, ed. The"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 348,
      "preview": "--- page 17 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "REFERENCES, CONT.",
      "line": 350
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 352,
      "preview": "- Schwartz DB, Barrocas A. Ethics and law. In: Mueller C, ed. The ASPEN adult nutrition support core"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 354,
      "preview": "--- page 18 ---"
    },
    {
      "type": "image",
      "section": "REFERENCES, CONT.",
      "line": 356,
      "content": "![img-2.jpeg](images/ba081275450fc914.png)"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 358,
      "preview": "Jay M. Mirtallo, M.S., R.Ph, BCNSP, FASHP, FASPEN"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 359,
      "preview": "The Professor Emeritus"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 360,
      "preview": "The Ohio State University, College of Pharmacy"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 361,
      "preview": "Clinical Practice Specialist"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 362,
      "preview": "American Society for Parenteral and Enteral Nutrition"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 363,
      "preview": "Delaware, Ohio"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 364,
      "preview": "As one of the pharmacy specialist pioneers, Professor Mirtallo was instrumental in leading cost-effe"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 366,
      "preview": "Professor Mirtallo has been very active in professional societies and is Past President of the Ameri"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 368,
      "preview": "As a representative to the Joint Commission, he served on the task force that created the Nutrition "
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 370,
      "preview": "--- page 19 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Relevant Financial Relationship Disclosure",
      "line": 372
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 374,
      "preview": "In accordance with our accreditor\u2019s Standards of Integrity and Independence in Accredited Continuing"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 376,
      "preview": "An ineligible company is any entity producing, marketing, re-selling, or distributing health care go"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 378,
      "preview": "The following persons in control of this activity\u2019s content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 380,
      "preview": "- Phil Ayers: Fresenius Kabi, consultant and speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 381,
      "preview": "- David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; "
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 382,
      "preview": "- Andrew Mays: Fresenius Kabi, speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 383,
      "preview": "- Jay Mirtallo: Fresenius Kabi, consultant"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 384,
      "preview": "- Kris Mogensen: Baxter, speaker; ThriveRx, advisory board; Pfizer, advisory board"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 386,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 388,
      "preview": "As required by the Standards of Integrity and Independence in Accredited Continuing Education defini"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Methods and CE Requirements",
      "line": 390
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 392,
      "preview": "This online activity consists of a combined total of 12 learning modules. Pharmacists and physicians"
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 394,
      "preview": "Participants must participate in the entire activity, complete the evaluation and all required compo"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 396
    },
    {
      "type": "text",
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 398,
      "preview": "Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "System Technical Requirements",
      "line": 400
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 402,
      "preview": "Courses and learning activities are delivered via your Web browser and Acrobat PDF. Users should hav"
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 404,
      "preview": "View Frequently Asked Questions for more information."
    }
  ],
  "images": [
    {
      "sha_name": "545f9225f87911e2.png",
      "original_ref": "img-0.jpeg",
      "page": 1,
      "relative_path": "images/545f9225f87911e2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/1_InterrelationsBetweenDiseaseandNutrition/images/545f9225f87911e2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "545f9225f87911e2"
    },
    {
      "sha_name": "fdca67f5a6069e0e.png",
      "original_ref": "img-1.jpeg",
      "page": 6,
      "relative_path": "images/fdca67f5a6069e0e.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/1_InterrelationsBetweenDiseaseandNutrition/images/fdca67f5a6069e0e.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "fdca67f5a6069e0e"
    },
    {
      "sha_name": "ba081275450fc914.png",
      "original_ref": "img-2.jpeg",
      "page": 18,
      "relative_path": "images/ba081275450fc914.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/1_InterrelationsBetweenDiseaseandNutrition/images/ba081275450fc914.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "ba081275450fc914"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754695701",
    "ts": "2025-08-08T23:28:21.278297+00:00"
  }
}